This job posting may have expired!
Use our `search` to find similar offers.
Similar jobs

Trial Mgmt Suite - Subject Matter Expert Lead

IQVIA Holdings Inc.

Various Locations

DUTIES AND RESPONSIBILITIES
•Develop an in-depth understanding of the Life Sc. DTMS - Clinical Product and underlying data assets and models/methods Define the solution concept design for building commercially viable products / custom solutions leveraging platform components, reusable modules and existing product capabilities
•Work closely with product management and product development to define and document the business and deployment processes
•Work closely with product management and product development to research, analyse, and derive business,
functional and technical requirements.
•Work with Sales team members in supporting RFP solutions proposals, deploying the products to clients and help with client specific business process and change management
REQUIRED QUALIFICATIONS TO BE SUCCESSFUL IN THIS ROLE
•5+ years of experience in Clinical Life Sciences
•5+ proven experience working with Clinical Operations and RBM (Risk based monitoring) business processes
•5+ years of experience in interacting with clients with products features & functionality
•Knowledge of enterprise customer requirements in data ingestion and migration, data processing and business
intelligence.
•Exceptional analytical and conceptual thinking skills.
•Excellent problem solving and analytical skills
•Excellent written, verbal communication and negotiating skills, with customers, team and stakeholders

At IQVIA, we believe in pushing the boundaries of human science and data science to make the biggest impact possible – to help our customers create a healthier world. The advanced analytics, technology solutions and contract research services we provide to the life sciences industry are made possible by our 67,000+ employees around the world who apply their insight, curiosity and intellectual courage every step of the way. Learn more at jobs.iqvia.com.

Job posted: 2020-10-21

3
購読する